Douglas Warner
EFFECTOR Therapeutics, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Douglas Warner as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:07 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04632381 · Intravenous Zotatifin in Adults With Mild or Moderate COVID-19Effector Therapeutics · completed · Corona Virus Infection · study director
- Ph2NCT04622007 · Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART)Effector Therapeutics · unknown · Non-small Cell Lung Cancer · study director
- Ph1/Ph2NCT04092673 · Study of eFT226 in Subjects With Selected Advanced Solid Tumor MalignanciesEffector Therapeutics · unknown · Solid Tumor, Adult · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:07 UTC. The ranking covers the 200 most relevant of 78 PubMed records, and a shared surname and initials can bring in a namesake. All 78 on PubMed
- Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.Lancet · 2015426 citationsRCR 13.7
- 358 citationsRCR 14.6
- 299 citationsRCR 8.2
- 290 citationsRCR 7.7
- Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial.Lancet Oncol · 2014233 citationsRCR 6.3
- Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.Stroke · 2005212 citationsRCR 6.5
- Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans.J Physiol · 1994209 citationsRCR 7.6
- A prospective, comparative trial of three anesthetics for elective supratentorial craniotomy. Propofol/fentanyl, isoflurane/nitrous oxide, and fentanyl/nitrous oxide.Anesthesiology · 1993172 citationsRCR 9.6
- Predictors of survival following cardiac arrest in patients undergoing noncardiac surgery: a study of 518,294 patients at a tertiary referral center.Anesthesiology · 2003164 citationsRCR 5.2
- Interscalene brachial plexus block with a continuous catheter insertion system and a disposable infusion pump.Anesth Analg · 2000148 citationsRCR 7.2